These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 17070947)
21. The development of China's medical biotech industry needs to be driven by innovation. Yu Z; Dai Y Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752 [TBL] [Abstract][Full Text] [Related]
22. Marriage guidance for collaborators. Hogan J Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497 [TBL] [Abstract][Full Text] [Related]
23. India aims to become the main bioinformatics hub. Jayaraman KS; Louët S Nat Biotechnol; 2004 Aug; 22(8):933. PubMed ID: 15286632 [No Abstract] [Full Text] [Related]
24. A European biotechnology transfer platform? Suojanen C N Biotechnol; 2009 Apr; 25(4):167-8. PubMed ID: 19429530 [No Abstract] [Full Text] [Related]
25. The scientific muscle of Brazil's health biotechnology. Ferrer M; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC8-12. PubMed ID: 15583686 [No Abstract] [Full Text] [Related]
26. FDA launches two research centers with academia. Fox JL Nat Biotechnol; 2014 Jul; 32(7):601. PubMed ID: 25004209 [No Abstract] [Full Text] [Related]
27. Marketing biotechnology with a Gallic flair. Jouanneau AC Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977 [No Abstract] [Full Text] [Related]
28. The US radon problem, policy, program and industry: achievements, challenges and strategies. Angell WJ Radiat Prot Dosimetry; 2008; 130(1):8-13. PubMed ID: 18583373 [TBL] [Abstract][Full Text] [Related]
29. Can Europe accelerate out of trouble? Nat Biotechnol; 2006 Sep; 24(9):1040. PubMed ID: 16964194 [No Abstract] [Full Text] [Related]
30. Global health public-private partnerships: IAVI, partnerships and capacity building. Hanlin R; Chataway J; Smith J Afr J Med Med Sci; 2007; 36 Suppl():69-75. PubMed ID: 17703568 [TBL] [Abstract][Full Text] [Related]
31. Indian Biotech Bazaar: a swot analysis. Kumar A Biotechnol J; 2007 May; 2(5):543-5. PubMed ID: 17479978 [TBL] [Abstract][Full Text] [Related]
32. Health-related biotechnology in Africa: managing the legislative and regulatory issues. Andanda AP Afr J Med Med Sci; 2007; 36 Suppl():55-61. PubMed ID: 17703566 [TBL] [Abstract][Full Text] [Related]
33. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research. Caulfield T Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021 [No Abstract] [Full Text] [Related]
35. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea. Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865 [No Abstract] [Full Text] [Related]
38. The promise of South African biotech. Akermann B; Kermani F Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404 [No Abstract] [Full Text] [Related]
39. China moves to reform biotech policies. Jia H Nat Biotechnol; 2004 Oct; 22(10):1197. PubMed ID: 15470442 [No Abstract] [Full Text] [Related]